| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
CONCISE REVIEW |
a Department of Medicine, University of Alberta, Edmonton, AB, Canada;
b Department of Pathology & Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Key Words. Autocrine growth • Growth factors • CD34+ cells • Cytokines • Chemokines
Correspondence:
Mariusz Z. Ratajczak, M.D., Ph.D., Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, University of Pennsylvania, 405A Stellar Chance Labs, 422 Curie Blvd., Philadelphia, Pennsylvania 19104, USA. Fax: 215-573-6317; e-mail: mariusz{at}mail.med.upenn.edu
Autocrine/paracrine regulatory mechanisms are believed to play a role in the pathophysiology of several hematologic malignancies. Evidence is accumulating that various growth factors, cytokines, and chemokines are expressed and secreted by normal early and differentiated hematopoietic cells and thus could also regulate normal hematopoiesis in an autocrine/paracrine manner. In this review we summarize recent advances in identification and understanding of the role of autocrine/paracrine axes in the growth of both malignant and normal human hematopoietic cells. Better understanding of intercellular crosstalk operating in normal and pathological states and the mechanisms regulating synthesis of these endogenously produced factors (potential targets for various pharmacological approaches) may allow us to improve antileukemia treatments, undertake more efficient ex vivo stem cell expansion, and develop other therapeutic strategies.
This article has been cited by other articles:
|
|
 |
|
  J. A. Hamilton, G. Whitty, P. Masendycz, N. J. Wilson, J. Jackson, D. De Nardo, and G. M. Scholz The Critical Role of the Colony-Stimulating Factor-1 Receptor in the Differentiation of Myeloblastic Leukemia Cells Mol. Cancer Res., March 1, 2008; 6(3): 458 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tei, T. Matsumoto, Y. Mifune, K. Ishida, K. Sasaki, T. Shoji, S. Kubo, A. Kawamoto, T. Asahara, M. Kurosaka, et al. Administrations of Peripheral Blood CD34-Positive Cells Contribute to Medial Collateral Ligament Healing via Vasculogenesis Stem Cells, March 1, 2008; 26(3): 819 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsumoto, A. Kawamoto, R. Kuroda, M. Ishikawa, Y. Mifune, H. Iwasaki, M. Miwa, M. Horii, S. Hayashi, A. Oyamada, et al. Therapeutic Potential of Vasculogenesis and Osteogenesis Promoted by Peripheral Blood CD34-Positive Cells for Functional Bone Healing Am. J. Pathol., October 1, 2006; 169(4): 1440 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Campard, M. Vasse, S. Rose-John, F. Poyer, M. Lamacz, and J.-P. Vannier Multilevel Regulation of IL-6R by IL-6-sIL-6R Fusion Protein According to the Primitiveness of Peripheral Blood-Derived CD133+ Cells Stem Cells, May 1, 2006; 24(5): 1302 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Honczarenko, Y. Le, M. Swierkowski, I. Ghiran, A. M. Glodek, and L. E. Silberstein Human Bone Marrow Stromal Cells Express a Distinct Set of Biologically Functional Chemokine Receptors Stem Cells, April 1, 2006; 24(4): 1030 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Oswald, C. Steudel, K. Salchert, B. Joergensen, C. Thiede, G. Ehninger, C. Werner, and M. Bornhauser Gene-Expression Profiling of CD34+ Hematopoietic Cells Expanded in a Collagen I Matrix Stem Cells, March 1, 2006; 24(3): 494 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Narducci, E. Scala, A. Bresin, E. Caprini, M. C. Picchio, D. Remotti, G. Ragone, F. Nasorri, M. Frontani, D. Arcelli, et al. Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV Blood, February 1, 2006; 107(3): 1108 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kirito, N. Fox, N. Komatsu, and K. Kaushansky Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1{alpha} Blood, June 1, 2005; 105(11): 4258 - 4263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lennartsson, T. Jelacic, D. Linnekin, and R. Shivakrupa Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit Stem Cells, January 1, 2005; 23(1): 16 - 43. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Oh, A. Moharita, J. G. Potian, I. P. Whitehead, J. C. Livingston, T. A. Castro, P. S. Patel, and P. Rameshwar Bone Marrow Stroma Influences Transforming Growth Factor-{beta} Production in Breast Cancer Cells to Regulate c-myc Activation of the Preprotachykinin-I Gene in Breast Cancer Cells Cancer Res., September 1, 2004; 64(17): 6327 - 6336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Reca, D. Mastellos, M. Majka, L. Marquez, J. Ratajczak, S. Franchini, A. Glodek, M. Honczarenko, L. A. Spruce, A. Janowska-Wieczorek, et al. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1 Blood, May 15, 2003; 101(10): 3784 - 3793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. D. Joshi, A. Dang, P. Yadav, J. Qian, P. S. Bandari, K. Chen, R. Donnelly, T. Castro, P. Gascon, A. Haider, et al. Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study Blood, November 1, 2001; 98(9): 2697 - 2706. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
